Anticanceragent 274 (Compound 1) is a Sorafenib analog that inhibits tumor cell growth, with IC50 values of 0.034 µM and 0.042 µM for SaOS-2 and MNNG-HOS cells, respectively. It exhibits low toxicity to normal cells and can be utilized in osteosarcoma and other tumor research.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
